Abstract
Duchenne muscular dystrophy (DMD) is characterized by progressive muscle necrosis. One of the major challenges for prescribing physical rehabilitation exercises for DMD patients is associated with the lack of a thorough knowledge of dystrophic muscle responsiveness to exercise. This study aims to understand the relationship between myogenic regulation, inflammation and oxidative stress parameters, and disease progression induced by downhill running in the skeletal muscle of an experimental model of DMD. Six-month-old C57BL/10 and C57BL/10-DMDmdx male mice were distributed into three groups: Control (C), mdx, and mdx + Exercise (mdx + Ex). Animals were trained in a downhill running protocol for seven weeks. The gastrocnemius muscle was subjected to histopathology, muscle regeneration (myoD and myogenin), inflammation (COX-2), oxidative stress (8-OHdG) immunohistochemistry markers, and gene expression (qPCR) of NF-kB and NADP(H)Oxidase 2 (NOX-2) analysis. In the mdx + Ex group, the gastrocnemius muscle showed a higher incidence of endomysial fibrosis and a lower myonecrosis percentage area. Immunohistochemical analysis revealed decreased myogenin immunoexpression in the mdx group, as well as accentuated immunoexpression of nuclear 8-OHdG in both mdx groups and increase in cytoplasmic 8-OHdG only in the mdx + Ex. COX-2 immunoexpression was related to areas of regeneration process and inflammatory infiltrate in the mdx group, while associated with areas of muscle fibrosis in the mdx + Ex. Moreover, the NF-kB gene expression was not influenced by exercise; however, a NAD(P)HOxidase 2 increase was observed. Oxidative stress and oxidative DNA damage play a significant role in the DMD phenotype progression induced by exercise, compromising cellular patterns resulting in increased endomysial fibrosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Acharyya S, Villalta SA, Bakkar N, Bupha-Intr T, Janssen PM, Carathers M, Li ZW, Beg AA, Ghosh S, Sahenk Z, Weinstein M, Gardner KL, Rafael-Fortney JA, Karin M, Tidball JG, Baldwin AS, Guttridge DC (2007) Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J Clin Invest 117(4):889–901. https://doi.org/10.1172/JCI30556
Alexakis C, Partridge T, Bou-Gharios G (2007) Implication of the satellite cell in dystrophic muscle fibrosis: a self-perpetuating mechanism of collagen overproduction. Am J Physiol Cell Physiol 293(2):C661–C669. https://doi.org/10.1152/ajpcell.00061.2007
Allen DG, Whitehead NP, Froehner SC (2016) Absence of dystrophin disrupts skeletal muscle signaling: roles of Ca2+, reactive oxygen species, and nitric oxide in the development of muscular dystrophy. Physiol Rev 96(1):253–305. https://doi.org/10.1152/physrev.00007.2015
Anderson CL, De Repentigny Y, Cifelli C, Marshall P, Renaud JM, Worton RG, Kothary R (2006) The mouse dystrophin muscle promoter/enhancer drives expression of mini-dystrophin in transgenic mdx mice and rescues the dystrophy in these mice. Mol Ther 14(5):724–734. https://doi.org/10.1016/j.ymthe.2006.04.013
Araujo APQC, Carvalho AAS, Cavalcanti EBU, Saute JAM, Carvalho E, França MC, Junior, Martinez ARM, Navarro MMM, Nucci A, Resende MBD, Gonçalves MVM, Gurgel-Giannetti J, Scola RH, Sobreira CFDR, Reed UC, Zanoteli E (2017) Brazilian consensus on Duchenne muscular dystrophy. Part 1: diagnosis, steroid therapy and perspectives. Arq Neuropsiquiatr 75(8):104–113. https://doi.org/10.1590/0004-282x20170112
Asfour HA, Allouh MZ, Said RS (2018) Myogenic regulatory factors: the orchestrators of myogenesis after 30 years of discovery. Exp Biol Med (Maywood) 243(2):118–128. https://doi.org/10.1177/1535370217749494
Barnabei MS, Martindale JM, Townsend D, Metzger JM (2011) Exercise and muscular dystrophy: implications and analysis of effects on musculoskeletal and cardiovascular systems. Compr Physiol 1(3):1353–1363. https://doi.org/10.1002/cphy.c100062
Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, Case LE, Clemens PR, Hadjiyannakis S, Pandya S, Street N, Tomezsko J, Wagner KR, Ward LM, Weber DR, DMD Care Considerations Working Group (2018) Diagnosis and management of duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol 17(3):251–267. https://doi.org/10.1016/S1474-4422(18)30024-3
Bondesen BA, Mills ST, Kegley KM, Pavlath GK (2004) The COX-2 pathway is essential during early stages of skeletal muscle regeneration. Am J Physiol Cell Physiol 287(2):C475–C483. https://doi.org/10.1152/ajpcell.00088.2004
Bou Saada Y, Zakharova V, Chernyak B, Dib C, Carnac G, Dokudovskaya S, Vassetzky YS (2017) Control of DNA integrity in skeletal muscle under physiological and pathological conditions. Cell Mol Life Sci 74(19):3439–3449. https://doi.org/10.1007/s00018-017-2530-0
Brussee V, Tardif F, Tremblay JP (1997) Muscle fibers of mdx mice are more vulnerable to exercise than those of normal mice. Neuromuscul Disord 7(8):487–492. https://doi.org/10.1016/s0960-8966(97)00115-6
Bulfield G, Siller WG, Wight PA, Moore KJ (1984) X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 81(4):1189–1192. https://doi.org/10.1073/pnas.81.4.1189
Chang NC, Chevalier FP, Rudnicki MA (2016) Satellite cells in muscular dystrophy - lost in polarity. Trends Mol Med 22(6):479–496. https://doi.org/10.1016/j.molmed.2016.04.002
Chen H, Qian Z, Zhang S, Tang J, Fang L, Jiang F, Ge D, Chang J, Cao J, Yang L, Cao X (2021) Silencing COX-2 blocks PDK1/TRAF4-induced AKT activation to inhibit fibrogenesis during skeletal muscle atrophy. Redox Biol 38:101774. https://doi.org/10.1016/j.redox.2020.101774
Ciciliot S, Schiaffino S (2015) Regeneration of mammalian skeletal muscle. basic mechanisms and clinical implications. Curr Pharm Des 16(8):906–914. https://doi.org/10.2174/138161210790883453
De Paepe B, De Bleecker JL (2013) Cytokines and chemokines as regulators of skeletal muscle inflammation: presenting the case of duchenne muscular dystrophy. Mediators Inflamm 2013:540370. https://doi.org/10.1155/2013/540370
Deconinck N, Dan B (2007) Pathophysiology of duchenne muscular dystrophy: current hypotheses. Pediatr Neurol 36(1):1–7. https://doi.org/10.1016/j.pediatrneurol.2006.09.016
Desguerre I, Mayer M, Leturcq F, Barbet JP, Gherardi RK, Christov C (2009) Endomysial fibrosis in duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation. J Neuropathol Exp Neurol 68(7):762–773. https://doi.org/10.1097/NEN.0b013e3181aa31c2
Doe J, Kaindl AM, Jijiwa M, de la Vega M, Hu H, Griffiths GS, Fontelonga TM, Barraza P, Cruz V, Van Ry P, Ramos JW, Burkin DJ, Matter ML (2017) PTRH2 gene mutation causes progressive congenital skeletal muscle pathology. Hum Mol Genet 15(8):1458–1464. https://doi.org/10.1093/hmg/ddx048
Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A (2021) Duchenne muscular dystrophy. Nat Rev Dis Primers 18(1):13. https://doi.org/10.1038/s41572-021-00248-3
Duddy W, Duguez S, Johnston H, Cohen TV, Phadke A, Gordish-Dressman H, Nagaraju K, Gnocchi V, Low S, Partridge T (2015) Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia. Skelet Muscle. https://doi.org/10.1186/s13395-015-0041-y
Durbeej M, Campbell KP (2002) Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr Opin Genet Dev 12(3):349–361. https://doi.org/10.1016/s0959-437x(02)00309-x
Engler AJ, Griffin MA, Sen S, Bönnemann CG, Sweeney HL, Discher DE (2004) Myotubes differentiate optimally on substrates with tissue-like stiffness: pathological implications for soft or stiff microenvironments. J Cell Biol 13(6):877–887. https://doi.org/10.1083/jcb.200405004
Eston RG, Mickleborough J, Baltzopoulos V (1995) Eccentric activation and muscle damage: biomechanical and physiological considerations during downhill running. Br J Sports Med 29(2):89–94. https://doi.org/10.1136/bjsm.29.2.89
Evans NP, Misyak SA, Robertson JL, Bassaganya-Riera J, Grange RW (2009) Immune-mediated mechanisms potentially regulate the disease time-course of duchenne muscular dystrophy and provide targets for therapeutic intervention. PM R 1(8):755–768. https://doi.org/10.1016/j.pmrj.2009.04.010
Flynn JM, Meadows E, Fiorotto M, Klein WH (2010) Myogenin regulates exercise capacity and skeletal muscle metabolism in the adult mouse. PLoS One 5(10):e13535https://doi.org/10.1371/journal.pone.0013535
Gao QQ, McNally EM (2015) The dystrophin complex: structure, function, and implications for therapy. Compr Physiol 5(3):1223–39. https://doi.org/10.1002/cphy.c140048
Grounds MD, Radley HG, Lynch GS, Nagaraju K, De Luca A (2008) Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of duchenne muscular dystrophy. Neurobiol Dis 31(1):1–19. https://doi.org/10.1016/j.nbd.2008.03.008
Halliwell B, Whiteman M (2004) Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 142(2):231–255. https://doi.org/10.1038/sj.bjp.0705776
Henríquez-Olguín C, Altamirano F, Valladares D, López JR, Allen PD, Jaimovich E (2015) Altered ROS production, NF-κB activation and interleukin-6 gene expression induced by electrical stimulation in dystrophic mdx skeletal muscle cells. Biochim Biophys Acta 1852(7):1410–1419. https://doi.org/10.1016/j.bbadis.2015.03.012
Hoffman EP, Brown RH Jr, Kunkel LM (1987) Dystrophin: the protein product of the duchenne muscular dystrophy locus. Cell 51(6):919–28. https://doi.org/10.1016/0092-8674(87)90579-4
Hyzewicz J, Ruegg UT, Takeda S (2015) Comparison of experimental protocols of physical exercise for mdx mice and duchenne muscular dystrophy patients. J Neuromuscul Dis 22(4):325–342. https://doi.org/10.3233/JND-150106
Jin Y, Murakami N, Saito Y, Goto Y, Koishi K, Nonaka I (2000) Expression of MyoD and myogenin in dystrophic mice, mdx and dy, during regeneration. Acta Neuropathol 99(6):619–627. https://doi.org/10.1007/s004010051172
Karpati G, Carpenter S, Prescott S (1988) Small-caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy. Muscle Nerve 11(8):795–803. https://doi.org/10.1002/mus.880110802
Khan MA, Khan MJ (2018) Nano-gold displayed anti-inflammatory property via NF-kB pathways by suppressing COX-2 activity. Artif Cells Nanomed Biotechnol 46(sup1):1149–1158. https://doi.org/10.1080/21691401.2018.1446968
Klaunig JE (2018) Oxidative stress and cancer. Curr Pharm Des 24(40):4771–4778. https://doi.org/10.2174/1381612825666190215121712
Kobayashi YM, Rader EP, Crawford RW, Campbell KP (2012) Endpoint measures in the mdx mouse relevant for muscular dystrophy pre-clinical studies. Neuromuscul Disord 22(1):34–42. https://doi.org/10.1016/j.nmd.2011.08.001
Kostek M (2019) Precision medicine and exercise therapy in duchenne muscular dystrophy. Sports (Basel) 7(3):64. https://doi.org/10.3390/sports7030064
Kostek MC, Gordon B (2018) Exercise is an adjuvant to contemporary dystrophy treatments. Exerc Sport Sci Rev 46(1):34–41. https://doi.org/10.1249/JES.0000000000000131
Kozakowska M, Pietraszek-Gremplewicz K, Jozkowicz A, Dulak J (2015) The role of oxidative stress in skeletal muscle injury and regeneration: focus on antioxidant enzymes. J Muscle Res Cell Motil 36(6):377–393. https://doi.org/10.1007/s10974-015-9438-9
Kumar A, Boriek AM (2003) Mechanical stress activates the nuclear factor-kappaB pathway in skeletal muscle fibers: a possible role in duchenne muscular dystrophy. FASEB J 17(3):386–396. https://doi.org/10.1096/fj.02-0542com
Lawler JM (2011) Exacerbation of pathology by oxidative stress in respiratory and locomotor muscles with duchenne muscular dystrophy. J Physiol 589(Pt 9):2161–70. https://doi.org/10.1113/jphysiol.2011.207456
Lazzarin MC, Quintana HT, Baptista VIA, Oliveira F (2020) Lack of dystrophin influences muscle inflammation but not myogenic regulatory factors after eccentric exercise in mdx mice. Motriz 26(3):1–9. https://doi.org/10.1590/S1980-6574202000030228
Li H, Malhotra S, Kumar A (2008) Nuclear factor-kappa B signaling in skeletal muscle atrophy. J Mol Med 86(10):1113–1126. https://doi.org/10.1007/s00109-008-0373-8
Lindsay A, McCourt PM, Karachunski P, Lowe DA, Ervasti JM (2018) Xanthine oxidase is hyper-active in duchenne muscular dystrophy. Free Radic Biol Med 129:364–371. https://doi.org/10.1016/j.freeradbiomed.2018.10.404
Loehr JA, Wang S, Cully TR, Pal R, Larina IV, Larin KV, Rodney GG (2018) NADPH oxidase mediates microtubule alterations and diaphragm dysfunction in dystrophic mice. eLife 30:7:e31732. https://doi.org/10.7554/eLife.31732
Manning J, O’Malley D (2015) What has the mdx mouse model of duchenne muscular dystrophy contributed to our understanding of this disease? J Muscle Res Cell Motil 36(2):155–167. https://doi.org/10.1007/s10974-015-9406-4
Marotta M, Sarria Y, Ruiz-Roig C, Munell F, Roig-Quilis M (2007) Laser microdissection-based expression analysis of key genes involved in muscle regeneration in mdx mice. Neuromuscul Disord 17(9–10):707–718. https://doi.org/10.1016/j.nmd.2007.05.007
Martins SG, Zilhão R, Thorsteinsdóttir S, Carlos AR (2021) Linking oxidative stress and dna damage to changes in the expression of extracellular matrix components. Front Genet 29:673002. https://doi.org/10.3389/fgene.2021.673002
Meadows E, Flynn JM, Klein WH (2011) Myogenin regulates exercise capacity but is dispensable for skeletal muscle regeneration in adult mdx mice. PLoS ONE 14(1):e16184. https://doi.org/10.1371/journal.pone.0016184
Messina S, Vita GL, Aguennouz M, Sframeli M, Romeo S, Rodolico C, Vita G (2011) Activation of NF-kappaB pathway in duchenne muscular dystrophy: relation to age. Acta Myol 30(1):16–23
Murach KA, Dungan CM, Peterson CA, McCarthy JJ (2019) Muscle fiber splitting is a physiological response to extreme loading in animals. Exerc Sport Sci Rev 47(2):108–115. https://doi.org/10.1249/JES.0000000000000181
Nakae Y, Stoward PJ, Bespalov IA, Melamede RJ, Wallace SS (2005) A new technique for the quantitative assessment of 8-oxoguanine in nuclear DNA as a marker of oxidative stress. application to dystrophin-deficient DMD skeletal muscles. Histochem Cell Biol 124(3–4):335–345. https://doi.org/10.1007/s00418-005-0037-5
Oeckinghaus A, Ghosh S (2009) The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol 1(4):a000034. https://doi.org/10.1101/cshperspect.a000034
Okano T, Yoshida K, Nakamura A, Sasazawa F, Oide T, Takeda S, Ikeda S (2005) Chronic exercise accelerates the degeneration-regeneration cycle and downregulates insulin-like growth factor-1 in muscle of mdx mice. Muscle Nerve 32(2):191–199. https://doi.org/10.1002/mus.20351
Paulsen G, Mikkelsen UR, Raastad T, Peake JM (2012) Leucocytes, cytokines and satellite cells: what role do they play in muscle damage and regeneration following eccentric exercise? Exerc Immunol Rev 18:42–97
Pessina P, Cabrera D, Morales MG, Riquelme CA, Gutiérrez J, Serrano AL, Brandan E, Muñoz-Cánoves P (2014) Novel and optimized strategies for inducing fibrosis in vivo: focus on duchenne muscular dystrophy. Skelet Muscle 25:7. https://doi.org/10.1186/2044-5040-4-7
Peterson JM, Guttridge DC (2008) Skeletal muscle diseases, inflammation, and NF-kappaB signaling: insights and opportunities for therapeutic intervention. Int Rev Immunol 27(5):375–387. https://doi.org/10.1080/08830180802302389
Purslow PP (2020) The structure and role of intramuscular connective tissue in muscle function. Front Physiol 19:495. https://doi.org/10.3389/fphys.2020.00495
Robbins JH, Scudiero DA, Otsuka F, Tarone RE, Brumback RA, Wirtschafter JD, Polinsky RJ, Barrett SF, Moshell AN, Scarpinato RG (1984) Hypersensitivity to DNA-damaging agents in cultured cells from patients with Usher’s syndrome and duchenne muscular dystrophy. J Neurol Neurosurg Psychiatry 47(4):391–398. https://doi.org/10.1136/jnnp.47.4.391
Rodriguez MC, Tarnopolsky MA (2003) Patients with dystrophinopathy show evidence of increased oxidative stress. Free Radic Biol Med 34(9):1217–20. https://doi.org/10.1016/s0891-5849(03)00141-2
Roig M, Roma J, Fargas A, Munell F (2004) Longitudinal pathologic study of the gastrocnemius muscle group in mdx mice. Acta Neuropathol 107(1):27–34. https://doi.org/10.1007/s00401-003-0773-3
Sabourin LA, Rudnicki MA (2000) The molecular regulation of myogenesis. Clin Genet 57(1):16–25. https://doi.org/10.1034/j.1399-0004.2000.570103.x
Sacco A, Mourkioti F, Tran R, Choi J, Llewellyn M, Kraft P, Shkreli M, Delp S, Pomerantz JH, Artandi SE, Blau HM (2010) Short telomeres and stem cell exhaustion model duchenne muscular dystrophy in mdx/mTR mice. Cell 143(7):1059–71. https://doi.org/10.1016/j.cell.2010.11.039
Shi X, Garry DJ (2006) Muscle stem cells in development, regeneration, and disease. Genes Dev 20(13):1692–708. https://doi.org/10.1101/gad.1419406
Smith LR, Barton ER (2018) Regulation of fibrosis in muscular dystrophy. Matrix Biol 68–69:602–615. https://doi.org/10.1016/j.matbio.2018.01.014
Souza LB, Maziero C, Lazzarin MC, Quintana HT, Tomé TC, Baptista VIA, de Oliveira F (2020) Presence of metalloproteinases 2 and 9 and 8-OHdG in the fibrotic process in skeletal muscle of Mdx mice. Acta Histochem 122(1):151458. https://doi.org/10.1016/j.acthis.2019.151458
Spaulding HR, Selsby JT (2018) Is exercise the right medicine for dystrophic muscle? Med Sci Sports Exerc 50(9):1723–1732. https://doi.org/10.1249/MSS.0000000000001639
Taniguti AP, Pertille A, Matsumura CY, Santo Neto H, Marques MJ (2011) Prevention of muscle fibrosis and myonecrosis in mdx mice by suramin, a TGF-β1 blocker. Muscle Nerve 43(1):82–87. https://doi.org/10.1002/mus.21869
Terada M, Kawano F, Ohira T, Nakai N, Nishimoto N, Ohira Y (2012) Effects of mechanical over-loading on the properties of soleus muscle fibers, with or without damage, in wild type and mdx mice. PLoS ONE 7(4):e34557. https://doi.org/10.1371/journal.pone.0034557
Terrill JR, Radley-Crabb HG, Iwasaki T, Lemckert FA, Arthur PG, Grounds MD (2013) Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathies. FEBS J 280(17):4149–4164. https://doi.org/10.1111/febs.12142
Thoma A, Lightfoot AP (2018) NF-kB and inflammatory cytokine signalling: role in skeletal muscle atrophy. Adv Exp Med Biol 1088:267–279. https://doi.org/10.1007/978-981-13-1435-3_12
Tomé TC, Quintana HT, Bortolin JA, Taffarel AA, Liberti EA, De Oliveira F (2019) Extensive burn injury causes bone collagen network alteration and growth delay related to RANK-L immunoexpression change. Connect Tissue Res 61(5):465–474. https://doi.org/10.1080/03008207.2019.1620220
Valavanidis A, Vlachogianni T, Fiotakis C (2009) 8-hydroxy-2’ -deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 27(2):120–139. https://doi.org/10.1080/10590500902885684
van Putten M, Hulsker M, Nadarajah VD, van Heiningen SH, van Huizen E, van Iterson M, Admiraal P, Messemaker T, den Dunnen JT, ‘t Hoen PA, Aartsma-Rus A (2012) The effects of low levels of dystrophin on mouse muscle function and pathology. PLoS ONE 7(2):e31937. https://doi.org/10.1371/journal.pone.0031937
Whitaker AM, Schaich MA, Smith MR, Flynn TS, Freudenthal BD (2017) Base excision repair of oxidative DNA damage: from mechanism to disease. Front Biosci (Landmark Ed) 22(9):1493–1522. https://doi.org/10.2741/4555
Whitehead NP, Yeung EW, Allen DG (2005) Muscle damage in mdx (dystrophic) mice: role of calcium and reactive oxygen species. Clin Exp Pharmacol Physiol 33(7):657–662. https://doi.org/10.1111/j.1440-1681.2006.04394.x
Whitehead NP, Yeung EW, Froehner SC, Allen DG (2010) Skeletal muscle NADPH oxidase is increased and triggers stretch-induced damage in the mdx mouse. PLoS ONE 20(12):e15354. https://doi.org/10.1371/journal.pone.0015354
Yin X, Tang Y, Li J, Dzuricky AT, Pu C, Fu F, Wang B (2017) Genetic ablation of P65 subunit of NF-κB in mdx mice to improve muscle physiological function. Muscle Nerve 56(4):759–767. https://doi.org/10.1002/mus.25517
Zammit PS (2017) Function of the myogenic regulatory factors Myf5, MyoD, myogenin and MRF4 in skeletal muscle, satellite cells and regenerative myogenesis. Semin Cell Dev Biol 72:19–32. https://doi.org/10.1016/j.semcdb.2017.11.011
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lazzarin, M.C., dos Santos, J.F., Quintana, H.T. et al. Duchenne muscular dystrophy progression induced by downhill running is accompanied by increased endomysial fibrosis and oxidative damage DNA in muscle of mdx mice. J Mol Histol 54, 41–54 (2023). https://doi.org/10.1007/s10735-022-10109-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10735-022-10109-2